Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 14, 2019 | Post-IPO Equity | $5.10B | 1 | Gilead Sciences | — | Detail |
Sep 17, 2018 | Post-IPO Equity | $300M | — | — | — | Detail |
Oct 5, 2017 | IPO | — | — | — | — | Detail |
Jan 22, 2015 | Grant | €2.50M | 1 | — | — | Detail |
Jan 13, 2014 | Grant | €2.90M | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 21, 2022
DAM
|
Pre-seed | $1.80M | Cryptocurrency | — |
Jun 1, 2022
Altitude
|
Seed | $2.10M | Blockchain | — |
Feb 23, 2022
Bware Labs
|
Series A | $6M | Blockchain | — |
Dec 2, 2021
Ignite Tournaments
|
Seed | $3M | Blockchain | — |
Dec 2, 2021
Ambire
|
Seed | $3.20M | Advertising | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gilead Sciences | Yes | Post-IPO Equity |
Van Herk Ventures | Yes | Post-IPO Equity |
The Institute for the Promotion of Innovation by Science and Technology in Flanders | Yes | Grant |
Thuja Capital | Yes | Series Unknown |
University of Antwerp | — | Grant |
Gilde Healthcare | — | Series Unknown |
Galapagos has acquired 7 organizations. Their most recent acquisition was BioFocus DPI on Sep 21, 2005. They acquired BioFocus DPI for $36.50M.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Sep 21, 2005
BioFocus DPI
|
Life Science | acquisition | $ 36.50M | Detail |
Dec 7, 2006
Inpharmatica
|
Biotechnology | acquisition | € 19.10M | Detail |
Jan 2, 2007
ProStrakan
|
Biopharma | acquisition | € 31M | Detail |
Feb 2, 2010
Argenta Discovery
|
Health Care | acquisition | — | Detail |
Jan 15, 2013
Cangenix
|
Biotechnology | acquisition | — | Detail |